Treatment for Advanced Ovarian Cancer Effective

Links shared publicly online about this topic.

  • 1,113
    total visits

Treatment for Advanced Ovarian Cancer Effective

disabled-world.com

New treatment regimen shown effective against advanced ovarian cancer

View full resource at disabled-world.com

Tags: Cancer, Ovarian Cancer, Women's Health

  • Share

Most Recently Shared on June 7, 2010 at 7:16 pm By:

OvarianCancer_ Ovarian Cancer OW

Treatment for Advanced Ovarian Cancer Effective: New treatment regimen shown effective against advanced ovarian ca... http://bit.ly/asdHX2

2 years ago...

Also Shared By:

Disabled World Disabled World

Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter

thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or mView full resource at thepharmaletter.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 12:13 pm By:

FiercePharma FiercePharma Health Site

Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma

2 months ago...

Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects

radiology.rsna.org — “Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific EffectsView full resource at radiology.rsna.org

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 6:46 am By:

OvarianCancer_ Ovarian Cancer OW OW Health

Advanced Ovarian Cancer: Multiparametric MR Imaging Demonstrates Response- and Metastasis-specific Effects [Geni... http://t.co/FYfxmOD8

2 months ago...

Arch Dermatol -- Abstract: Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer, March 19, 2012, Girouard et al. 0 (2012): archdermatol.2012.288v1

archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgeryView full resource at archderm.ama-assn.org

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 12:41 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer [Observation]: Conclusions  Although p... http://t.co/Uc8Yiazv

2 months ago...

Ovarian Cancer

springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...View full resource at springer.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 6:27 pm By:

OvarianCancer_ Ovarian Cancer OW OW Health

Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK

3 months ago...

Leukemia gene mutations linked to survival odds - Yahoo! News

news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 6:42 pm By:

HealthTrendster HealthTrendster Health Executive

Leukemia gene mutations linked to survival odds - (Reuters) - Advances in genetic profiling are paving the way for m... http://t.co/0EfukO57

3 months ago...

Leukemia gene mutations linked to survival odds - Yahoo! News

news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 5:57 pm By:

BoneCancer_OW Bone Cancer OW OW Health

Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/NSC3KcOm

3 months ago...

Leukemia gene mutations linked to survival odds

health.yahoo.net — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 5:55 pm By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/lIf45igw

3 months ago...

Leukemia study links gene mutations to survival chances | Health & Fitness | Life | Toronto Sun

torontosun.com — “Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research.View full resource at torontosun.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 4:56 pm By:

BoneCancer_OW Bone Cancer OW OW Health

Leukemia study links gene mutations to survival chances: Advances in genetic profiling are paving the way for mo... http://t.co/aNUkXYIa

3 months ago...

Leukemia gene mutations linked to survival odds - Yahoo! News

news.yahoo.com — “From Yahoo! News: (Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies, published in the latest edition of the New England Journal of Medicine, show that genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets. ...View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 11:36 pm By:

BoneCancer_OW Bone Cancer OW OW Health

Leukemia gene mutations linked to survival odds: (Reuters) - Advances in genetic profiling are paving the way fo... http://t.co/g3SXV91M

3 months ago...

Leukemia gene mutations linked to survival odds | Reuters

reuters.com — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to newView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 9:21 pm By:

MedicalNews Medical News Health News

Leukemia gene mutations linked to survival odds http://t.co/M2HCNVVQ

3 months ago...

Leukemia gene mutations linked to survival odds | Reuters

reuters.com — “(Reuters) - Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to newView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 9:13 pm By:

Reuters_Health Reuters Health Health News

Leukemia gene mutations linked to survival odds http://t.co/Ufz5NLrc

3 months ago...

Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA

medicalnewstoday.com — “The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food andView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 27, 2012 at 10:05 pm By:

mnt_healthnews MNT Health News Health News

Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA http://t.co/rGglGwAy #healthnews

4 months ago...

Innovative computer algorithm identifies clinically prognostic marker for cancer

news-medical.net — “Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 18, 2012 at 8:01 am By:

Ovarian_Cancer_ News-Medical.Net Health News

Ovarian Cancer News: Innovative computer algorithm identifies clinically prognostic marker for cancer: Researche... http://t.co/xC6TYAcw

5 months ago...

Faulty proteins may prove significant in identifying new treatments for ovarian cancer

medicalxpress.com — “A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on January 13, 2012 at 9:02 pm By:

physorg_health PhysOrg Health News Health News

Faulty proteins may prove significant in identifying new treatments for ovarian cancer http://t.co/kx5Z66aY

5 months ago...

Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours

news-medical.net — “Circadian Technologies Limited announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 9, 2012 at 5:39 am By:

Lung_Cancer_ News-Medical.Net Health News

Lung Cancer News: Circadian initiates VGX-100 Phase 1 trial in advanced solid tumours: Circadian Technologies Li... http://t.co/I2cWoG6D

5 months ago...

Advertisement